European Companies Search Engine

EU funding (€4,700,000): Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production Hor 1 May 2018 EU Research and Innovation programme "Horizon"

Overview

Text

Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production

iConsensus will provide innovative analytical, hardware, software and high-throughput (HTP) solutions for the development, monitoring and control of mammalian cell cultivation process producing biopharmaceuticals. iConsensus will develop an analytical platform with on-line/at-line sensors and detection methods measuring multiple factors in the cell culture and the produced biopharmaceutical. Under advanced data management, the analytical platform will be integrated in new micro-bioreactors for HTP screening on one hand and in classical stirred tank vessel bioreactor on the other hand. Based on the analytical information, feedback control will be applied. When deemed suitable, implementation in GMP production of the sensing and control tools will be carried on.


Funded Companies:

Company name Funding amount
Bayer AG €0.00
Beckman Coulter GmbH €263,161
Byondis B.V. €0.00
Glaxosmithkline Research & Development Ltd. €0.00
Iprasense €71,000
Ipratech SA €150,000
Kantisto B.V. €308,500
Kungliga Tekniska Hoegskolan €1,414,354
Micronit B.V. €206,934
Micronit Holding B.V. €469,066
Paia Biotech GmbH €250,000
Pfizer Ltd. €0.00
Presens Precision Sensing GmbH €454,000
Ramcon A/S €0.00
Rentschler Biopharma SE €0.00
Rheinisch-Westfaelische Technische Hochschule Aachen €374,000
Sanofi-Aventis Deutschland GmbH €0.00
Svanholm.COM ApS €83,485
UCB Biopharma €0.00
Universitaet Hohenheim €355,500
Universite de Mons €300,000

Source: https://cordis.europa.eu/project/id/777397

The filing refers to a past date, and does not necessarily reflect the current state.